Abstract PO3-13-09: Personalized ctDNA testing for detection of molecular residual disease in patients with localized HR+ breast cancer: temporal dynamics and impact on clinical outcomesArielle J. Medford, Aditya Bardia, Laura M. Spring et al.|Cancer Research|2024Cited by 1
Nectin-4 expression in primary breast cancer and associated clinical outcomes.Arielle J. Medford, Aditya Bardia, Gad Getz et al.|Journal of Clinical Oncology|2024Cited by 1